CJC1295(without DAC)5mg+IPA5mg

This combination pairs a GHRH analog with a ghrelin-receptor-based growth hormone secretagogue. CJC-1295 without DAC stimulates the pituitary through GHRH receptor pathways, while ipamorelin acts through growth hormone secretagogue receptors. Researchers study this pairing because the two mechanisms may produce complementary GH pulse activity. The combination is commonly examined in relation to endocrine signaling, IGF-1 response, recovery research, sleep-related hormone patterns, and body-composition markers. It is especially relevant for studying how GHRH and ghrelin-mimetic pathways interact within the growth hormone axis.